JP2002020292A - Composition containing ascorbic acid phosphoric esters - Google Patents
Composition containing ascorbic acid phosphoric estersInfo
- Publication number
- JP2002020292A JP2002020292A JP2000199213A JP2000199213A JP2002020292A JP 2002020292 A JP2002020292 A JP 2002020292A JP 2000199213 A JP2000199213 A JP 2000199213A JP 2000199213 A JP2000199213 A JP 2000199213A JP 2002020292 A JP2002020292 A JP 2002020292A
- Authority
- JP
- Japan
- Prior art keywords
- ascorbic acid
- composition
- salt
- sodium
- phosphate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 title claims abstract description 71
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 235000010323 ascorbic acid Nutrition 0.000 title claims abstract description 37
- 239000011668 ascorbic acid Substances 0.000 title claims abstract description 37
- 229960005070 ascorbic acid Drugs 0.000 title claims abstract description 35
- 150000002148 esters Chemical class 0.000 title abstract description 6
- -1 aluminum ion Chemical class 0.000 claims abstract description 27
- 150000003839 salts Chemical class 0.000 claims abstract description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 10
- 229910052782 aluminium Inorganic materials 0.000 claims abstract description 10
- 239000003945 anionic surfactant Substances 0.000 claims abstract description 10
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 10
- 239000011575 calcium Substances 0.000 claims abstract description 10
- 239000006188 syrup Substances 0.000 claims abstract description 9
- 235000020357 syrup Nutrition 0.000 claims abstract description 9
- 150000005846 sugar alcohols Chemical class 0.000 claims abstract description 7
- 150000002772 monosaccharides Chemical class 0.000 claims abstract description 6
- 229920001542 oligosaccharide Polymers 0.000 claims abstract description 6
- 150000002482 oligosaccharides Chemical class 0.000 claims abstract description 5
- 229920002472 Starch Polymers 0.000 claims abstract description 4
- 239000008107 starch Substances 0.000 claims abstract description 4
- 235000019698 starch Nutrition 0.000 claims abstract description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 28
- 235000021317 phosphate Nutrition 0.000 claims description 27
- 239000010452 phosphate Substances 0.000 claims description 26
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 25
- 238000003860 storage Methods 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 14
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 10
- 230000007774 longterm Effects 0.000 abstract description 3
- 238000004321 preservation Methods 0.000 abstract 2
- 235000002639 sodium chloride Nutrition 0.000 description 29
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 25
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 10
- 239000000551 dentifrice Substances 0.000 description 10
- 150000001875 compounds Chemical class 0.000 description 9
- 208000007565 gingivitis Diseases 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- 239000000377 silicon dioxide Substances 0.000 description 9
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 9
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 8
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 8
- 239000002304 perfume Substances 0.000 description 7
- 239000000606 toothpaste Substances 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 229940034610 toothpaste Drugs 0.000 description 6
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 229910002027 silica gel Inorganic materials 0.000 description 5
- 239000000741 silica gel Substances 0.000 description 5
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 4
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- WINXNKPZLFISPD-UHFFFAOYSA-M Saccharin sodium Chemical compound [Na+].C1=CC=C2C(=O)[N-]S(=O)(=O)C2=C1 WINXNKPZLFISPD-UHFFFAOYSA-M 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 239000001768 carboxy methyl cellulose Chemical class 0.000 description 4
- 229960004106 citric acid Drugs 0.000 description 4
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229940085605 saccharin sodium Drugs 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 4
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 239000011230 binding agent Substances 0.000 description 3
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 3
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 3
- 239000006071 cream Substances 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 210000004195 gingiva Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 210000000214 mouth Anatomy 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 3
- 229960000401 tranexamic acid Drugs 0.000 description 3
- 235000010493 xanthan gum Nutrition 0.000 description 3
- 239000000230 xanthan gum Substances 0.000 description 3
- 229920001285 xanthan gum Polymers 0.000 description 3
- 229940082509 xanthan gum Drugs 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 2
- ACFGRWJEQJVZTM-LEJBHHMKSA-L Magnesium L-ascorbic acid-2-phosphate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(OP([O-])([O-])=O)=C1O ACFGRWJEQJVZTM-LEJBHHMKSA-L 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 2
- 150000008051 alkyl sulfates Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 229910000323 aluminium silicate Inorganic materials 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229940072107 ascorbate Drugs 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- ULDHMXUKGWMISQ-UHFFFAOYSA-N carvone Chemical compound CC(=C)C1CC=C(C)C(=O)C1 ULDHMXUKGWMISQ-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229960002303 citric acid monohydrate Drugs 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 2
- 229960003720 enoxolone Drugs 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 2
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- 229940051866 mouthwash Drugs 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000006072 paste Substances 0.000 description 2
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 2
- 102220240796 rs553605556 Human genes 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 235000010413 sodium alginate Nutrition 0.000 description 2
- 239000000661 sodium alginate Substances 0.000 description 2
- 229940005550 sodium alginate Drugs 0.000 description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 2
- 239000004299 sodium benzoate Substances 0.000 description 2
- 235000010234 sodium benzoate Nutrition 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 229960000414 sodium fluoride Drugs 0.000 description 2
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 235000010356 sorbitol Nutrition 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical compound COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- 229960003500 triclosan Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical class [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical class CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- KRLBLPBPZSSIGH-CSKARUKUSA-N (6e)-3,7-dimethylnona-1,6-dien-3-ol Chemical compound CC\C(C)=C\CCC(C)(O)C=C KRLBLPBPZSSIGH-CSKARUKUSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 102000008490 2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine Human genes 0.000 description 1
- 108010020504 2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine Proteins 0.000 description 1
- OQFQOOSSKHJIAW-UHFFFAOYSA-N 3-(2,3-dihydroxypropylsulfonyl)propane-1,2-diol Chemical compound OCC(O)CS(=O)(=O)CC(O)CO OQFQOOSSKHJIAW-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 239000005973 Carvone Substances 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000270722 Crocodylidae Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-ZXXMMSQZSA-N D-iditol Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-ZXXMMSQZSA-N 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 108010001682 Dextranase Proteins 0.000 description 1
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Chemical class 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Chemical class 0.000 description 1
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical class OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- XJCCHWKNFMUJFE-CGQAXDJHSA-N Maltotriitol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O[C@@H]([C@H](O)[C@@H](O)CO)[C@H](O)CO)O[C@H](CO)[C@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 XJCCHWKNFMUJFE-CGQAXDJHSA-N 0.000 description 1
- 101100366137 Mesembryanthemum crystallinum SODCC.1 gene Proteins 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical compound CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 101100096142 Panax ginseng SODCC gene Proteins 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920000388 Polyphosphate Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 102000004079 Prolyl Hydroxylases Human genes 0.000 description 1
- 108010043005 Prolyl Hydroxylases Proteins 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- POXJXWXPDYFTJM-ZAFYKAAXSA-N [(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-yl] dihydrogen phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1OP(O)(O)=O POXJXWXPDYFTJM-ZAFYKAAXSA-N 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical class [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Chemical class 0.000 description 1
- 229920000615 alginic acid Chemical class 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- 235000010210 aluminium Nutrition 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- 239000005515 coenzyme Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- IDASTKMEQGPVRR-UHFFFAOYSA-N cyclopenta-1,3-diene;zirconium(2+) Chemical compound [Zr+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 IDASTKMEQGPVRR-UHFFFAOYSA-N 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- LNNWVNGFPYWNQE-GMIGKAJZSA-N desomorphine Chemical compound C1C2=CC=C(O)C3=C2[C@]24CCN(C)[C@H]1[C@@H]2CCC[C@@H]4O3 LNNWVNGFPYWNQE-GMIGKAJZSA-N 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- FXNRKXSSLJKNGH-UHFFFAOYSA-L dipotassium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [K+].[K+].[O-]P([O-])(F)=O FXNRKXSSLJKNGH-UHFFFAOYSA-L 0.000 description 1
- POULHZVOKOAJMA-UHFFFAOYSA-M dodecanoate Chemical compound CCCCCCCCCCCC([O-])=O POULHZVOKOAJMA-UHFFFAOYSA-M 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 229910021485 fumed silica Inorganic materials 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 150000002306 glutamic acid derivatives Chemical class 0.000 description 1
- 150000002332 glycine derivatives Chemical class 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 229940094522 laponite Drugs 0.000 description 1
- 229940070765 laurate Drugs 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- XCOBTUNSZUJCDH-UHFFFAOYSA-B lithium magnesium sodium silicate Chemical compound [Li+].[Li+].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Na+].[Na+].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].[Mg+2].O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3.O1[Si](O2)([O-])O[Si]3([O-])O[Si]1([O-])O[Si]2([O-])O3 XCOBTUNSZUJCDH-UHFFFAOYSA-B 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229920000609 methyl cellulose Chemical class 0.000 description 1
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Chemical class 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- SKDZEPBJPGSFHS-UHFFFAOYSA-N n,n-bis(2-hydroxyethyl)tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)N(CCO)CCO SKDZEPBJPGSFHS-UHFFFAOYSA-N 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- 235000015927 pasta Nutrition 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 208000028169 periodontal disease Diseases 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 239000001205 polyphosphate Substances 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical class C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 150000003334 secondary amides Chemical class 0.000 description 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 1
- 101150017120 sod gene Proteins 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Chemical class 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 229940045845 sodium myristate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- JUQGWKYSEXPRGL-UHFFFAOYSA-M sodium;tetradecanoate Chemical compound [Na+].CCCCCCCCCCCCCC([O-])=O JUQGWKYSEXPRGL-UHFFFAOYSA-M 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 1
- 229960002799 stannous fluoride Drugs 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000009637 wintergreen oil Substances 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0063—Periodont
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Physiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、アスコルビン酸リ
ン酸エステル類を含有する口腔用、外皮用等の組成物に
関する。[0001] The present invention relates to a composition for oral cavity and dermis containing a phosphoric acid ester of ascorbic acid.
【0002】[0002]
【従来の技術及び発明が解決しようとする課題】アスコ
ルビン酸リン酸エステル及びその塩は、生体中で種々の
酵素活性発現に重要な役割を演じ、多様な生理活性を持
つことが知られている。特に、プロリル及びリジルヒド
ロキシラーゼの補酵素として作用し、コラーゲン合成に
必須であるとされている。また、近年、生体内に産生さ
れた過剰の活性酸素を消去し、生体組織を酸素傷害から
守る抗酸化ビタミンとしても注目されており、多様な生
理活性を持つことが知られている。2. Description of the Related Art It is known that ascorbic acid phosphate and salts thereof play an important role in the expression of various enzyme activities in living organisms and have various physiological activities. . In particular, it acts as a coenzyme for prolyl and lysyl hydroxylase and is said to be essential for collagen synthesis. In recent years, it has also attracted attention as an antioxidant vitamin that eliminates excess active oxygen produced in the living body and protects living tissues from oxygen damage, and is known to have various physiological activities.
【0003】従来、アスコルビン酸リン酸エステル及び
その塩を含有する組成物としては、化粧料(特開昭62
−298508号、特開平3−63208号公報)、美
白化粧料(特開昭63−243014号公報、特開平1
−305009号、同3−133914号公報)、口腔
用薬剤(特開昭62−96408号公報)、浴用剤(特
開昭62−96410号公報)、口腔用組成物(特開平
2−292210号、同2−292211号、同4−1
73727号公報)、皮膚外用剤(特開平3−3490
8号、同7−206632号、同8−133951号公
報)など、数多くのものが提案されている。[0003] Conventionally, compositions containing ascorbic acid phosphate and salts thereof include cosmetics (JP-A-62
-298508, JP-A-3-63208), whitening cosmetics (JP-A-63-243014, JP-A-1
305,093 and 3-133914), oral agents (Japanese Patent Application Laid-Open No. 62-96408), bath agents (Japanese Patent Application Laid-Open No. 62-96410), and oral compositions (Japanese Patent Application Laid-Open No. 2-292210). 2-292221, 4-1
No. 73727), an external preparation for skin (JP-A-3-3490)
No. 8, No. 7-206632, and No. 8-133951).
【0004】しかしながら、アスコルビン酸リン酸エス
テル又はその塩を各種組成物に配合した場合、カルシウ
ムや金属、微生物、pHの影響等によって不安定にな
り、その結果、アスコルビン酸とリン酸に分解する問題
が発生し、このため組成を安定に保つことが要望され
た。However, when ascorbic acid phosphate or a salt thereof is blended in various compositions, the composition becomes unstable due to the influence of calcium, metal, microorganisms, pH and the like, and as a result, it is decomposed into ascorbic acid and phosphoric acid. Therefore, it was required to keep the composition stable.
【0005】この問題を解決するため、酸化防止剤やキ
レート剤を配合したり、また水との接触を極力抑えるた
め、組成物を粉末状や顆粒状にする検討もなされてきた
(特開平7−252127号公報)。しかし、このよう
なアスコルビン酸リン酸エステル又はその塩を配合した
組成物においては、ただ単にアスコルビン酸リン酸エス
テル類を安定に配合するだけでなく、その使用に際し
て、より高い生理活性を発現するように配合することが
必要である。In order to solve this problem, studies have been made to mix an antioxidant and a chelating agent, and to make the composition powdery or granular in order to minimize the contact with water (Japanese Patent Application Laid-Open No. Hei 7 (1994) -107). -252127). However, such a composition containing ascorbic acid phosphate or a salt thereof not only stably mixes ascorbic acid phosphates, but also exhibits a higher physiological activity when used. It is necessary to mix it.
【0006】このような点で、特にペースト状、液状、
クリーム状のような使用性に優れた剤型を選択し、適度
な起泡力と分散性を維持すると共に、これら製剤中でア
スコルビン酸リン酸エステル又はその塩の構造を維持し
たまま、適用する生体等に吸収されることが望まれ、こ
のような水を含む剤型において、アスコルビン酸リン酸
エステル及びその塩を安定配合し、その効果を有効に発
揮させる技術の開発が望まれる。[0006] In this respect, in particular, paste, liquid,
Select a dosage form with excellent usability, such as a cream, and apply it while maintaining appropriate foaming power and dispersibility and maintaining the structure of ascorbic acid phosphate or a salt thereof in these preparations. It is desired to be absorbed by a living body or the like, and in such a water-containing dosage form, it is desired to develop a technique for stably blending ascorbic acid phosphate and a salt thereof and effectively exhibiting its effect.
【0007】従って、本発明は、アスコルビン酸リン酸
エステル及びその塩が安定かつ活性な状態で配合された
組成物を提供することを目的とする。Accordingly, an object of the present invention is to provide a composition containing ascorbic acid phosphate and a salt thereof in a stable and active state.
【0008】[0008]
【課題を解決するための手段及び発明の実施の形態】本
発明者は、上記目的を達成するため鋭意検討を行った結
果、アスコルビン酸リン酸エステル又はその塩を含有す
る組成物において、アニオン界面活性剤と、炭素数4以
上の単糖アルコール、オリゴ糖アルコール、還元水飴類
から選ばれる1種又は2種以上を配合すると共に、カル
シウム及びアルミニウムイオン源の含有量の組成物全体
の10%(質量百分率、以下同じ)未満に局限するこ
と、更に、組成物を25℃にて1ヶ月保存した後のpH
が8.0以上、特に好ましくは8.5〜9.5となるよ
うに初期のpHを調整することにより、アスコルビン酸
リン酸エステル又はその塩を含有する組成物の経時安定
性が向上し、長期保存した後でもアスコルビン酸リン酸
エステル又はその塩の残存率の低下が効果的に防止さ
れ、その効果を有効に発現させることを知見した。この
場合、このアスコルビン酸リン酸エステル又はその塩を
配合した組成物の多くは、その初期pHを8.0以上、
特に8.5〜9.5に調整しても、製造後室温付近の保
存でも1ヶ月以内にpHが大きく変化し、pHが8.0
より低くなる場合があり、このように25℃、1ヶ月保
存後のpHが8.0より低くなった場合にはアスコルビ
ン酸リン酸エステル及びその塩の安定配合が達成されな
いものであり、従って25℃で1ヶ月保存した後の組成
物のpH値が、アスコルビン酸リン酸エステル及びその
塩を安定かつ活性な状態で配合させるために重要である
ことを見出したものである。Means for Solving the Problems and Embodiments of the Invention As a result of intensive studies to achieve the above object, the present inventor has found that a composition containing ascorbic acid phosphate or a salt thereof has an anionic interface. An activator and one or more selected from monosaccharide alcohols having 4 or more carbon atoms, oligosaccharide alcohols, and reduced starch syrup are blended, and the content of calcium and aluminum ion sources is 10% of the total composition ( Mass percentage, hereinafter the same), and the pH of the composition after storage at 25 ° C. for 1 month.
Is adjusted to 8.0 or more, particularly preferably 8.5 to 9.5, whereby the stability with time of the composition containing ascorbic acid phosphate or a salt thereof is improved, It has been found that even after long-term storage, a decrease in the residual ratio of ascorbic acid phosphate or a salt thereof is effectively prevented, and the effect is effectively exhibited. In this case, most of the compositions containing the ascorbic acid phosphate or a salt thereof have an initial pH of 8.0 or more,
In particular, even if the pH is adjusted to 8.5 to 9.5, the pH greatly changes within one month even after storage at around room temperature after production, and the pH becomes 8.0.
If the pH after storage at 25 ° C. for one month is lower than 8.0, stable combination of the ascorbic acid phosphate and its salt cannot be achieved, and therefore, It has been found that the pH value of the composition after storage at 1 ° C. for one month is important for incorporating ascorbic acid phosphate and salts thereof in a stable and active state.
【0009】以下、本発明につき更に詳しく説明する。
本発明の組成物は、(A)アスコルビン酸リン酸エステ
ル又はその塩、(B)アニオン界面活性剤、(C)炭素
数が4以上の単糖アルコール、オリゴ糖アルコール及び
還元水飴類から選ばれる1種又は2種以上の糖アルコー
ルを含有すると共に、カルシウム及びアルミニウムイオ
ン源の含有量が組成物全体の10質量%未満であり、か
つ25℃にて1ヶ月保存した後のpHが8.0以上であ
ることを特徴とする。Hereinafter, the present invention will be described in more detail.
The composition of the present invention is selected from (A) ascorbic acid phosphate or a salt thereof, (B) an anionic surfactant, (C) a monosaccharide alcohol having 4 or more carbon atoms, an oligosaccharide alcohol, and reduced starch syrup. It contains one or more sugar alcohols, has a calcium and aluminum ion source content of less than 10% by mass of the whole composition, and has a pH of 8.0 after storage at 25 ° C. for one month. It is characterized by the above.
【0010】ここで、アスコルビン酸リン酸エステル
は、アスコルビン酸の2,3,5,6位のいずれかの水
酸基の1個又は2個以上がリン酸、ポリリン酸等の化合
物のエステルとなったものであり、例えばアスコルビン
酸−2−リン酸エステル、アスコルビン酸−3−リン酸
エステル、アスコルビン酸−6−リン酸エステル、アス
コルビン酸−2−ポリリン酸エステル等が挙げられる。
また、その塩類としては、ナトリウム塩、カリウム塩、
カルシウム塩、マグネシウム塩等のアルカリ金属塩、ア
ルカリ土類金属塩が挙げられる。これらの中では、特に
口腔用として用いる場合、歯周疾患の予防・改善効果の
点から、アスコルビン酸リン酸エステルマグネシウム塩
やナトリウム塩が好適に用いられる。[0010] The ascorbic acid phosphoric acid ester is an ester of a compound such as phosphoric acid or polyphosphoric acid in which one or more of the hydroxyl groups at the 2,3,5,6-positions of ascorbic acid. And examples thereof include ascorbic acid-2-phosphate, ascorbic acid-3-phosphate, ascorbic acid-6-phosphate, and ascorbic acid-2-polyphosphate.
The salts include sodium salts, potassium salts,
Examples thereof include alkali metal salts such as calcium salts and magnesium salts, and alkaline earth metal salts. Among them, particularly when used for the oral cavity, magnesium or sodium ascorbic acid phosphate is preferably used from the viewpoint of the effect of preventing and improving periodontal disease.
【0011】その配合量は、組成物全体の0.001〜
10%、特に0.01〜5%とすることが好ましい。配
合量が少なすぎると、その効果が十分に発揮されず、多
すぎると使用感が低下する場合がある。The compounding amount is 0.001 to 0.001 of the whole composition.
It is preferably 10%, particularly preferably 0.01 to 5%. If the amount is too small, the effect is not sufficiently exhibited, and if it is too large, the feeling in use may be reduced.
【0012】次に、アニオン界面活性剤は、適度な起泡
力を付与したり、分散性を付与する等の目的で配合され
る。この場合、アニオン界面活性剤はその配合によりア
スコルビン酸リン酸エステル又はその塩の安定性を低下
させると言われてきたが、本発明においては、組成物の
25℃、1ヶ月保存後のpHを8.0以上とすることに
より、アニオン界面活性剤を配合しても、アスコルビン
酸リン酸エステル又はその塩の安定化配合に成功したも
のである。Next, the anionic surfactant is blended for the purpose of imparting an appropriate foaming power or imparting dispersibility. In this case, the anionic surfactant is said to reduce the stability of the ascorbic acid phosphate or a salt thereof by its combination. However, in the present invention, the pH of the composition after storage at 25 ° C. for one month is adjusted. By setting it to 8.0 or more, even if an anionic surfactant is blended, stabilization blending of ascorbic acid phosphate or a salt thereof is successful.
【0013】ここで、アニオン界面活性剤としては、従
来公知の各種のもの、例えば、アルキル硫酸エステル
塩、ポリオキシエチレンアルキル硫酸エステル塩、α−
スルホ脂肪酸エステル塩、α−オレフィンスルホン酸
塩、アルキル又はヒドロキシアルキルエーテルカルボン
酸塩、N−アシル化タウリン、N−アシル化グリシン、
N−アシル化アスパラギン酸塩、N−アシル化ザルコシ
ン、N−アシル化グルタミン酸塩、モノアルキルリン酸
エステル塩、アルキルアミドエーテル硫酸エステル塩、
アルキル(ポリ)グリセリルエーテルスルホン酸塩、ア
ルキル(ポリ)グリセリルエーテルカルボン酸塩、二級
アミド型N−アシルアミノ酸塩、酒石酸アルキルアミ
ド、リンゴ酸アルキルアミド、クエン酸アルキルアミ
ド、アルキル(ポリ)グリセリルスルホン酸塩、モノグ
リセリドコハク酸エステル塩等が挙げられるが、これら
の中ではアルキル硫酸エステル塩が好ましい。As the anionic surfactant, various conventionally known anionic surfactants, for example, alkyl sulfate, polyoxyethylene alkyl sulfate, α-
Sulfo fatty acid ester salts, α-olefin sulfonates, alkyl or hydroxyalkyl ether carboxylates, N-acylated taurine, N-acylated glycine,
N-acylated aspartate, N-acylated sarcosine, N-acylated glutamate, monoalkyl phosphate, alkylamide ether sulfate,
Alkyl (poly) glyceryl ether sulfonate, alkyl (poly) glyceryl ether carboxylate, secondary amide type N-acyl amino acid salt, alkyltartaric acid, malic acid alkylamide, citric acid alkylamide, alkyl (poly) glyceryl sulfone Acid salts, monoglyceride succinate salts and the like, among which alkyl sulfate salts are preferred.
【0014】アニオン界面活性剤の配合量は、適宜選定
されるが、組成物全体の0.1〜10%、特に0.5〜
3%であることが好ましい。The amount of the anionic surfactant is appropriately selected, but may be 0.1 to 10%, preferably 0.5 to 10% of the whole composition.
Preferably, it is 3%.
【0015】本発明の組成物には、更に炭素数4以上の
単糖アルコール、オリゴ糖アルコール、還元水飴類の1
種又は2種以上を配合する。炭素数が4個以上の単糖ア
ルコールとしては、具体的にはエリスリトール、キシリ
トール、マンニトール、ソルビトール、ガラクチトー
ル、イジトール等である。オリゴ糖アルコールとして
は、例えばマルチトール、ラクチトール、パラチニッ
ト、マルトトリイトール、イソマルトトリイトールが挙
げられる。還元水飴類としては、例えば、低糖化還元水
飴、高糖化還元水飴、還元麦芽糖水飴が挙げられる。こ
れらは、1種のみでもよいし、2種以上を組み合わせ配
合しても構わない。The composition of the present invention further comprises a monosaccharide alcohol having 4 or more carbon atoms, an oligosaccharide alcohol, and reduced syrup.
Seeds or two or more kinds are blended. Specific examples of the monosaccharide alcohol having 4 or more carbon atoms include erythritol, xylitol, mannitol, sorbitol, galactitol, and iditol. Examples of the oligosaccharide alcohol include maltitol, lactitol, palatinit, maltotriitol, and isomalttriitol. Examples of the reduced syrup include reduced saccharified reduced syrup, highly saccharified reduced syrup, and reduced maltose syrup. These may be used alone or in combination of two or more.
【0016】これら糖アルコールの配合量は、組成物全
体の1〜80%、特に5〜60%とすることができる
が、組成物中に含まれる水分量に対して、重量比として
0.5以上、より望ましくは0.5〜2.0、更に望ま
しくは0.75〜1.5となるような割合で配合するこ
とが好ましく、これによりアスコルビン酸リン酸エステ
ル又はその塩の効果を更に有効に発揮させることができ
る。The content of these sugar alcohols can be 1 to 80%, especially 5 to 60% of the whole composition, and is 0.5% by weight based on the amount of water contained in the composition. As described above, it is more preferable to mix at a ratio of 0.5 to 2.0, more preferably 0.75 to 1.5, whereby the effect of ascorbic acid phosphate or a salt thereof is more effective. Can be demonstrated.
【0017】なお、炭素数が3の単糖アルコールである
グリセリンには、このような効果はない。Glycerin, which is a monosaccharide alcohol having 3 carbon atoms, has no such effect.
【0018】本発明の組成物においては、カルシウムイ
オン源、アルミニウムイオン源、例えばリン酸水素カル
シウム、第3リン酸カルシウム、ピロリン酸カルシウム
等のカルシウム含有化合物、水酸化アルミニウム等のア
ルミニウム含有化合物の含有量を組成物全体の10%未
満、好ましくは1%以下、更に好ましくは0.1%以下
とするものであり、特にはこれらカルシウム含有化合
物、アルミニウム含有化合物を配合しないことが好まし
い。カルシウム含有化合物が多く存在すると、アスコル
ビン酸リン酸エステル又はその塩がカルシウムと反応し
て不溶性のカルシウム塩を形成し、アルミニウム含有化
合物が多く存在すると、アルミニウムによりアスコルビ
ン酸リン酸エステル又はその塩の分解が促進されるが、
カルシウム含有化合物、アルミニウム含有化合物の含有
量を組成物全体の10%未満に局限することにより、こ
れらの不都合を防止することができる。In the composition of the present invention, the contents of a calcium ion source, an aluminum ion source, for example, calcium-containing compounds such as calcium hydrogen phosphate, tribasic calcium phosphate and calcium pyrophosphate, and aluminum-containing compounds such as aluminum hydroxide are determined. The content is less than 10%, preferably 1% or less, more preferably 0.1% or less of the whole product, and it is particularly preferable not to mix these calcium-containing compounds and aluminum-containing compounds. When a large amount of a calcium-containing compound is present, the ascorbic acid phosphate or a salt thereof reacts with calcium to form an insoluble calcium salt, and when a large amount of an aluminum-containing compound is present, decomposition of the ascorbic acid phosphate or a salt thereof by aluminum is caused. Is promoted,
By limiting the contents of the calcium-containing compound and the aluminum-containing compound to less than 10% of the whole composition, these disadvantages can be prevented.
【0019】本発明の組成物は、口腔用、外皮用等、種
々の用途に使用でき、またその剤型は、種々選定される
が、ペースト状、液状、クリーム状等の剤型に調製する
ことが好ましい。The composition of the present invention can be used for various uses such as for the oral cavity and for the outer skin, and its dosage form is variously selected, and is prepared into dosage forms such as paste, liquid and cream. Is preferred.
【0020】本発明の組成物には、その用途、剤型等に
応じて、上記成分に加え、公知の成分を配合することが
できる。例えば、口腔用組成物は、練歯磨、液状歯磨等
の歯磨類、歯肉マッサージクリーム、局所塗布剤、洗口
剤として調製されるが、歯磨類の場合は、研磨剤、粘結
剤、甘味剤、香料、各種有効成分などを常用量で配合し
得る。The composition of the present invention may contain known components in addition to the above components, depending on the use, dosage form and the like. For example, the oral composition is prepared as a toothpaste, a dentifrice such as a liquid dentifrice, a gingival massage cream, a topical application, and a mouthwash, but in the case of a dentifrice, an abrasive, a binder, and a sweetener. , Fragrance, various active ingredients and the like can be blended in a usual dose.
【0021】この場合、研磨剤としては、シリカゲル、
沈降性シリカ、アルミノシリケート、ジルコノシリケー
ト(チタニウム結合性シリカ)等のシリカ系研磨剤が好
ましく、その他炭酸マグネシウム、ベントナイト、ポリ
メタクリル酸メチル等を配合することができる。In this case, silica gel,
Silica-based abrasives such as sedimentable silica, aluminosilicate and zirconosilicate (titanium-binding silica) are preferable, and magnesium carbonate, bentonite, polymethyl methacrylate and the like can be added.
【0022】また、粘結剤としては、カラギーナン、カ
ルボキシメチルセルロースナトリウム、メチルセルロー
ス、ヒドロキシエチルセルロース等のセルロース誘導
体、アルギン酸ナトリウム、アルギン酸プロピレングリ
コール等のアルギン酸誘導体、キサンタンガム、ジェラ
ンガム、トランガントガム、カラヤガム等のガム類、ポ
リビニルアルコール、ポリアクリル酸ナトリウム、カル
ボキシビニルポリマー等の合成粘結剤、シリカゲル、ビ
ーガム、ラポナイト等の無機粘結剤などの1種又は2種
以上を配合し得る。Examples of the binder include cellulose derivatives such as carrageenan, sodium carboxymethylcellulose, methylcellulose and hydroxyethylcellulose; alginic acid derivatives such as sodium alginate and propylene glycol alginate; gums such as xanthan gum, gellan gum, trangant gum and karaya gum. , Polyvinyl alcohol, sodium polyacrylate, carboxyvinyl polymer, and the like, and one or more kinds of inorganic binders such as silica gel, veegum, and laponite.
【0023】粘稠剤としては、上記糖アルコールが用い
られるほか、必要に応じ、グリセリン、プロピレングリ
コール、ポリエチレングリコール等を配合し得、また、
界面活性剤として、上記アニオン界面活性剤に加え、ラ
ウリン酸デカグリセリル、ミリスチン酸ジエタノールア
ミド等の非イオン性界面活性剤、ベタイン系等の両性界
面活性剤を配合し得る。As the thickener, the above sugar alcohol is used, and if necessary, glycerin, propylene glycol, polyethylene glycol and the like can be blended.
As the surfactant, a nonionic surfactant such as decaglyceryl laurate and diethanolamide myristate, and an amphoteric surfactant such as betaine may be blended in addition to the anionic surfactant.
【0024】香料成分としては、メントール、アネトー
ル、カルボン、オイゲノール、n−デシルアルコール、
シトロネロール、α−テルピネオール、シネオール、リ
ナロール、エチルリナロール、ワニリン、チモール、ペ
パーミント油、スペアミント油、ウインターグリーン
油、丁字油、ユーカリ油等の香料を単独で又は組み合わ
せて配合し得る。更に、サッカリンナトリウム、ペリラ
ルチン、ソーマチン等の甘味剤を配合し得る。As the fragrance component, menthol, anethole, carvone, eugenol, n-decyl alcohol,
Flavors such as citronellol, α-terpineol, cineol, linalool, ethyl linalool, crocodile, thymol, peppermint oil, spearmint oil, wintergreen oil, clove oil, eucalyptus oil and the like can be used alone or in combination. Furthermore, sweeteners such as saccharin sodium, perillartin, thaumatin and the like can be added.
【0025】また、本発明には、クロルヘキシジン、塩
化ベンゼトニウム、塩化ベンザルコニウム、塩化セチル
ピリジニウム、塩化デカリニウム等の陽イオン性殺菌
剤、トリクロサン、ヒノキチオール、ビオゾール等のフ
ェノール性化合物、デキトラナーゼ、ムタナーゼ、リゾ
チーム、アミラーゼ、プロテアーゼ、溶菌酵素、SOD
等の酵素、モノフルオロリン酸ナトリウム、モノフルオ
ロリン酸カリウムなどのアルカリ金属モノフルオロフォ
スフェート、フッ化ナトリウム、フッ化第一錫などのフ
ッ化物、トラネキサム酸、イプシロンアミノカプロン
酸、アラントイン、ジヒドロコレスタノール、グリチル
リチン酸類、グリチルレチン酸、グリセロフォスフェー
ト、クロロフィル、塩化ナトリウム、キシリトール、塩
化亜鉛、水溶性無機リン酸化合物、ビタミンA、ビタミ
ンB群、ビタミンE等のビタミン類及びそれらの誘導体
等、公知の有効成分を1種又は2種以上配合することが
できる。Also, the present invention provides a cationic fungicide such as chlorhexidine, benzethonium chloride, benzalkonium chloride, cetylpyridinium chloride, decalinium chloride, a phenolic compound such as triclosan, hinokitiol, biosol, etc., dextranase, mutanase, lysozyme. , Amylase, protease, lytic enzyme, SOD
Enzymes such as sodium monofluorophosphate and potassium monofluorophosphate, fluorides such as sodium fluoride and stannous fluoride, tranexamic acid, epsilon aminocaproic acid, allantoin, dihydrocholestanol Glycyrrhizic acids, glycyrrhetinic acid, glycerophosphate, chlorophyll, sodium chloride, xylitol, zinc chloride, water-soluble inorganic phosphate compounds, vitamins such as vitamin A, vitamin B group, vitamin E and derivatives thereof, and the like. One or more components can be blended.
【0026】本発明の組成物は、25℃、1ヶ月保存後
のpHが8.0以上、好ましくは8.0〜9.5、特に
は8.5〜9.5となるように初期pHを調整する。こ
こで、初期pHではなく、1ヶ月保存後のpHとしたの
は、多くの組成物の場合、室温付近でも製造後1ヶ月以
内にpHが大きく変化し、その後安定化することから2
5℃、1ヶ月保存後のpHが重要であることを知見した
からである。The composition of the present invention has an initial pH such that the pH after storage at 25 ° C. for one month is 8.0 or more, preferably 8.0 to 9.5, particularly 8.5 to 9.5. To adjust. Here, the pH after storage for one month was used instead of the initial pH because, for many compositions, the pH greatly changed within one month after production even at around room temperature and was stabilized thereafter.
This is because it was found that the pH after storage at 5 ° C. for one month was important.
【0027】この場合、pH変動は、配合成分により相
違し、例えばシリカゲルを配合した場合は初期pHに対
し25℃、1ヶ月保存後のpHが上昇し、沈降性シリカ
を配合した場合には逆にpHが降下する。従って、初期
pHを調整して25℃、1ヶ月保存後のpHを上記所用
のpHにするには、組成物の処方に応じ、初期pHを2
5℃、1ヶ月保存後の設定pHより低く又は高くなるよ
うに調整する。必要によっては、予備試験により初期p
Hと25℃、1ヶ月保存後のpHとの関係を調べておく
手法を採用し得る。なお、pHの調整は、一般に使用さ
れるpH調整剤を用いることができるが、水酸化ナトリ
ウム、水酸化カリウムを好適に使用することができ、ま
た、水溶性のクエン酸塩、リン酸塩、炭酸塩、重炭酸塩
等も好ましく用いることができる。In this case, the pH fluctuation differs depending on the blending components. For example, when silica gel is blended, the pH after storage at 25 ° C. for one month increases with respect to the initial pH, and when precipitated silica is blended, reverse. The pH drops. Therefore, in order to adjust the initial pH to 25 ° C. and the pH after storage for one month to the required pH, the initial pH is adjusted to 2 according to the formulation of the composition.
Adjust so as to be lower or higher than the set pH after storage at 5 ° C for 1 month. If necessary, a preliminary test will
A method of examining the relationship between H and the pH after storage at 25 ° C. for one month may be employed. In addition, for pH adjustment, a commonly used pH adjuster can be used, but sodium hydroxide and potassium hydroxide can be suitably used, and water-soluble citrate, phosphate, Carbonates, bicarbonates and the like can also be preferably used.
【0028】[0028]
【発明の効果】本発明のアスコルビン酸リン酸エステル
類含有組成物は、アスコルビン酸リン酸エステル又はそ
の塩が安定かつ活性な状態で配合されたものであり、長
期保存後においてもその効果を有効に発揮する。The ascorbic acid phosphate-containing composition of the present invention contains ascorbic acid phosphate or a salt thereof in a stable and active state, and its effects are effective even after long-term storage. Demonstrate.
【0029】[0029]
【実施例】以下、実験例及び実施例と比較例を示し、本
発明を具体的に説明するが、本発明は下記の実施例に制
限されるものではない。EXAMPLES Hereinafter, the present invention will be described in detail with reference to experimental examples, examples, and comparative examples, but the present invention is not limited to the following examples.
【0030】[実験例]下記に示す処方の歯磨剤を調製
した。調整後1〜3ヶ月の歯磨剤を使用し、1週間の使
用テストを実施し、歯肉炎の改善効果を観察した。即
ち、健常人10名が下記A、B歯磨を1週間使用し、そ
の後2日間口腔清掃を中止して歯肉の状態を自己評価
し、アンケートに記入した。なお、各歯磨剤使用の間は
1週間以上あけた。また、アンケートでは、前歯部上下
顎の歯肉を観察し、図1(A)〜(C)を参考にして下
記のように点数化した。結果を表1に示す。 0:歯肉炎なし、図1(A) 1:歯肉炎わずかにある、図1(B) 2:歯肉炎あり、図1(C) なお、図において、Xが歯牙、Yが歯肉で、Zが歯肉炎
部分を示す。 歯磨剤A 歯磨剤B L−アスコルビン酸−2−リン酸エステルマグネシウム塩0.3% 0.3% 沈降性シリカ 15 % 15 % プロピレングリコール 3.5% 3.5% カルボキシメチルセルロース 1.5% 1.5% パラオキシ安息香酸ブチル 0.1% 0.1% サッカリンナトリウム 0.2% 0.2% 香料 1 % 1 % ラウリル硫酸ナトリウム 1.5% 1.5% 二酸化チタン 0.5% 0.5% クエン酸 0.1% 0.1% 70%ソルビット液 50 % − 85%グリセリン − 40% 水酸化ナトリウム 0.3% 0.35%精製水 残 残 計 100.0%100.0% pH(初期) 8.93 8.96 pH(25℃1ヶ月後) 8.58 8.60 糖アルコールの対水分量(重量比) 0.76 0Experimental Example A dentifrice having the following formulation was prepared. Using a dentifrice for 1 to 3 months after the adjustment, a use test was carried out for one week, and the effect of improving gingivitis was observed. That is, ten healthy persons used the following toothpastes A and B for one week, and then stopped oral cleaning for two days, self-evaluated the gingival condition, and filled out a questionnaire. In addition, one week or more was left between each use of the dentifrice. In the questionnaire, the gums of the upper and lower jaw of the anterior teeth were observed and scored as follows with reference to FIGS. 1 (A) to 1 (C). Table 1 shows the results. 0: No gingivitis, FIG. 1 (A) 1: Slight gingivitis, FIG. 1 (B) 2: Gingivitis, FIG. 1 (C) In the figure, X indicates teeth, Y indicates gingiva, and Z indicates gingiva. Indicates a gingivitis part. Dentifrice A Dentifrice B L-ascorbic acid-2-phosphate magnesium salt 0.3% 0.3% Precipitable silica 15% 15% Propylene glycol 3.5% 3.5% Carboxymethylcellulose 1.5% 1 0.5% Butyl paraoxybenzoate 0.1% 0.1% Sodium saccharin 0.2% 0.2% Fragrance 1% 1% Sodium lauryl sulfate 1.5% 1.5% Titanium dioxide 0.5% 0.5% Citric acid 0.1% 0.1% 70% Sorbit solution 50% -85% glycerin-40% Sodium hydroxide 0.3% 0.35% Purified water Residue Total 100.0% 100.0% pH (initial 8.93 8.96 pH (1 month after 25 ° C.) 8.58 8.60 Water content (weight ratio) of sugar alcohol 0.760
【0031】[0031]
【表1】 [Table 1]
【0032】[実施例1〜5、比較例1〜4]下記の共
通組成に表2の成分(シリカ、ソルビット又はグリセリ
ン)を配合した歯磨剤を調製した。これらの歯磨剤の調
製直後及び25℃で1ヶ月、6ヶ月、18ヶ月保存した
後のpHを測定した。また、60℃恒温槽中に1ヶ月間
保存した後の保存品、40℃恒温槽中に6ヶ月間保存し
た後の保存品、及び25℃で18ヶ月保存した後の保存
品のアスコルビン酸リン酸エステルマグネシウム塩の残
存率を測定した。結果を表2に示す。Examples 1 to 5 and Comparative Examples 1 to 4 Dentifrices were prepared by blending the components shown in Table 2 (silica, sorbite or glycerin) with the following common composition. The pH was measured immediately after preparation of these dentifrices and after storage at 25 ° C. for 1, 6, and 18 months. Phosphorous ascorbate of a preserved product stored for 1 month in a 60 ° C constant temperature bath, a preserved product stored for 6 months in a 40 ° C constant temperature bath, and a preserved product stored for 18 months at 25 ° C The residual ratio of the acid ester magnesium salt was measured. Table 2 shows the results.
【0033】 共通組成 L−アスコルビン酸−2−リン酸エステルマグネシウム塩0.3 % プロピレングリコール 3.5 カルボキシメチルセルロース 1.5 パラオキシ安息香酸ブチル 0.1 サッカリンナトリウム 0.2 香料 1 ラウリル硫酸ナトリウム 1.5 二酸化チタン 0.5 クエン酸 0.1 水酸化ナトリウム (適量)約0.3 シリカ 表2 ソルビット 表2 グリセリン 表2精製水 残 計 100.0%Common composition L-ascorbic acid-2-phosphate magnesium salt 0.3% propylene glycol 3.5 carboxymethylcellulose 1.5 butyl parahydroxybenzoate 0.1 sodium saccharin 0.2 fragrance 1 sodium lauryl sulfate 1.5 Titanium dioxide 0.5 Citric acid 0.1 Sodium hydroxide (appropriate amount) about 0.3 Silica Table 2 Sorbit Table 2 Glycerin Table 2 Purified water Balance 100.0%
【0034】[0034]
【表2】 [Table 2]
【0035】 [実施例6]練歯磨 プロピレングリコール 5 % 70%ソルビット 50 カラギーナン 1.2 サッカリンナトリウム 0.2 ラウリル硫酸ナトリウム 1.2 パラオキシ安息香酸エチル 0.1 アスコルビン酸−2−リン酸エステルマグネシウム塩 0.2 クエン酸1水和物 0.2 ジルコノシリケート 18 無水ケイ酸(トクヤマ社製) 3 香料 0.9 水酸化ナトリウム 適量 精製水 残 合 計 100% 初期pH 9.28 25℃1M後pH 8.80Example 6 Toothpaste Propylene glycol 5% 70% Sorbite 50 Carrageenan 1.2 Sodium saccharin 0.2 Sodium lauryl sulfate 1.2 Ethyl parahydroxybenzoate 0.1 Ascorbic acid-2-phosphate magnesium salt 0 .2 citric acid monohydrate 0.2 zirconocene silicate 18 silicic anhydride (manufactured by Tokuyama Corp.) 3 perfume 0.9 sodium hydroxide qs purified water balance total 100% initial pH 9.28 25 ° C. 1M after pH 8 .80
【0036】 [実施例7]練歯磨 ポリエチレングリコール400 5 % 70%ソルビット 40 キサンタンガム 1.1 キシリット 10 ラウリル硫酸ナトリウム 0.9 ミリスチン酸ジエタノールアミド 0.9 パルミチン酸 0.5 アスコルビン酸−2−リン酸エステルナトリウム塩 1 クエン酸1水和物 0.5 パラオキシ安息香酸エチル 0.1 アルミノシリケート 20 香料 1 精製水 残 合 計 100% 初期pH 8.71 25℃1M後pH 8.92Example 7 Toothpaste Polyethylene glycol 400 5% 70% Sorbite 40 Xanthan gum 1.1 Xylit 10 Sodium lauryl sulfate 0.9 Myristic acid diethanolamide 0.9 Palmitic acid 0.5 Ascorbic acid-2-phosphate sodium salt 1 citric acid monohydrate 0.5 ethyl parahydroxybenzoate 0.1 aluminosilicate 20 perfume 1 purified water balance total 100% initial pH 8.71 25 ° C. 1M after pH 8.92
【0037】 [実施例8]練歯磨 プロピレングリコール400 4 % ソルビット液(60%) 40 カルボキシメチルセルロース 2 サッカリンナトリウム 0.15 ラウリル硫酸ナトリウム 1 ラウロイルサルコシンナトリウム 0.2 安息香酸ナトリウム 0.5 トラネキサム酸 0.05 アスコルビン酸リン酸エステルマグネシウム塩 0.05 酒石酸ナトリウム 0.02 チタニウム結合性シリカ 20 火成性シリカ 1 香料 1 水酸化ナトリウム 適量 精製水 残 合 計 100% 初期pH 9.05 25℃1M後pH 8.61Example 8 Toothpaste Propylene glycol 400 4% sorbite solution (60%) 40 Carboxymethylcellulose 2 Saccharin sodium 0.15 Sodium lauryl sulfate 1 Lauroyl sarcosine sodium 0.2 Sodium benzoate 0.5 Tranexamic acid 0.05 phosphoric acid ester magnesium salt 0.05 sodium tartrate ascorbate 0.02 titanium binding silica 20 pyrogenic silica 1 perfume 1 sodium hydroxide qs purified water balance total 100% initial pH 9.05 25 ° C. 1M after pH 8. 61
【0038】 [実施例9]練歯磨 プロピレングリコール 5 % ソルビット液(60%) 60 アルギン酸ナトリウム 3 サッカリンナトリウム 0.15 ラウリル硫酸ナトリウム 1 パラオキシ安息香酸ブチル 0.5 トリクロサン 0.1 アスコロビン酸−2−リン酸エステルナトリウム塩 1 トリポリリン酸ナトリウム 1 ミリスチン酸ナトリウム 0.2 シリカゲル 20 香料 1 水酸化ナトリウム 適量 精製水 残 合 計 100% 初期pH 7.91 25℃1M後pH 8.58Example 9 Toothpaste Propylene glycol 5% Sorbite solution (60%) 60 Sodium alginate 3 Sodium saccharin 0.15 Sodium lauryl sulfate 1 Butyl paraoxybenzoate 0.5 Triclosan 0.1 Ascorbic acid-2-phosphate sodium salt 1 sodium tripolyphosphate 1 sodium myristate 0.2 silica gel 20 perfume 1 sodium qs purified water balance total 100% initial pH hydroxide 7.91 25 ° C. 1M after pH 8.58
【0039】 [実施例10]練歯磨 ポリアクリル酸ナトリウム 0.5 % キサンタンガム 0.5 プロピレングリコール 5 70%ソルビット液 50 サッカリンナトリウム 0.1 安息香酸ナトリウム 0.3 ラウリル硫酸ナトリウム 1.5 トラネキサム酸 0.1 アスコルビン酸−2−リン酸エステルマグネシム塩 0.5 トリエタノールアミン 2.5 酒石酸 2 dl−α−トコフェロール 0.2 オウバクエキス 0.05 フッ化ナトリウム 0.2 シリカゲル 10 沈降性シリカ 10 香料 1 炭酸ナトリウム 適量 精製水 残 合 計 100% 初期pH 8.71 25℃1M後pH 8.68Example 10 Toothpaste Sodium polyacrylate 0.5% Xanthan gum 0.5 Propylene glycol 5 70% sorbite solution 50 Saccharin sodium 0.1 Sodium benzoate 0.3 Sodium lauryl sulfate 1.5 Tranexamic acid 0. DESCRIPTION OF SYMBOLS 1 Ascorbic acid-2-phosphate ester magnesium salt 0.5 Triethanolamine 2.5 Tartaric acid 2 dl-α-tocopherol 0.2 Oak extract 0.05 Sodium fluoride 0.2 Silica gel 10 Precipitable silica 10 Perfume 1 Carbonate sodium qs purified water balance total 100% initial pH 8.71 25 ° C. 1M after pH 8.68
【0040】 [実施例11]洗口剤 エタノール 10 % グリセリン 5 ソルビット 5 マンニトール 3 マルチトール 3 ポリオキシエチレン(60)硬化ヒマシ油 1.0 ラウリル硫酸ナトリウム 0.1 アスコルビン酸−2−リン酸エステルマグネシウム塩 0.2 酢酸トコフェロール 0.05 香料 0.3 精製水 残 合 計 100% 初期pH 8.44 25℃1M後pH 8.49[Example 11] Mouthwash ethanol 10% glycerin 5 sorbitol 5 mannitol 3 maltitol 3 polyoxyethylene (60) hydrogenated castor oil 1.0 sodium lauryl sulfate 0.1 magnesium ascorbic acid-2-phosphate ester salt 0.2 tocopherol acetate 0.05 perfume 0.3 purified water balance total 100% initial pH 8.44 25 ° C. 1M after pH 8.49
【0041】 [実施例12]口腔用パスタ セタノール 20 % スクワラン 5 P.O.E(40)硬化ヒマシ油 0.1 キシリトール 8 ソルビタンモノオレイン酸エステル 1 ラウリル硫酸ナトリウム 0.2 グリチルレチン酸 0.1 サッカリンナトリウム 0.6 アスコルビン酸リン酸エステルナトリウム塩 0.3 クエン酸 0.5 無水ケイ酸 3 香料 0.3 水酸化カリウム 適量 精製水 残 合 計 100% 初期pH 8.25 25℃1M後pH 8.38Example 12 Oral Pasta Cetanol 20% Squalane 5P. O. E (40) Hardened castor oil 0.1 Xylitol 8 Sorbitan monooleate 1 Sodium lauryl sulfate 0.2 Glycyrrhetinic acid 0.1 Saccharin sodium 0.6 Ascorbic acid phosphate sodium salt 0.3 Citric acid 0.5 Silicic anhydride acid 3 perfume 0.3 potassium hydroxide qs purified water balance total 100% initial pH 8.25 25 ° C. 1M after pH 8.38
【図1】前歯部の歯肉の状態を説明するもので、(A)
は歯肉炎のない状態、(B)は歯肉炎が若干ある状態、
(C)は歯肉炎がかなり認められる状態である。BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a view for explaining a gingival state of an anterior tooth part.
Is a state without gingivitis, (B) is a state with some gingivitis,
(C) is a state in which gingivitis is considerably recognized.
X 歯牙 Y 歯肉 Z 歯肉炎 X Teeth Y Gingiva Z Gingivitis
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61P 1/02 A61P 1/02 Fターム(参考) 4C076 AA06 BB23 CC24 DD02 DD67Q EE30Q FF63 4C083 AA112 AB032 AB172 AB242 AB282 AB472 AC022 AC122 AC131 AC132 AC242 AC302 AC432 AC482 AC622 AC792 AC812 AC862 AD042 AD092 AD211 AD272 AD302 AD352 AD532 AD641 AD642 AD662 BB05 CC41 DD22 EE33 4C086 AA01 AA02 DA34 ──────────────────────────────────────────────────続 き Continued on the front page (51) Int.Cl. 7 Identification symbol FI theme coat ゛ (Reference) A61P 1/02 A61P 1/02 F-term (Reference) 4C076 AA06 BB23 CC24 DD02 DD67Q EE30Q FF63 4C083 AA112 AB032 AB172 AB242 AB282 AB472 AC022 AC122 AC131 AC132 AC242 AC302 AC432 AC482 AC622 AC792 AC812 AC862 AD042 AD092 AD211 AD272 AD302 AD352 AD532 AD641 AD642 AD662 BB05 CC41 DD22 EE33 4C086 AA01 AA02 DA34
Claims (3)
はその塩、(B)アニオン界面活性剤、(C)炭素数が
4以上の単糖アルコール、オリゴ糖アルコール及び還元
水飴類から選ばれる1種又は2種以上の糖アルコールを
含有すると共に、カルシウム及びアルミニウムイオン源
の含有量が組成物全体の10質量%未満であり、かつ2
5℃にて1ヶ月保存した後のpHが8.0以上であるこ
とを特徴とするアスコルビン酸リン酸エステル類含有組
成物。1. One selected from (A) ascorbic acid phosphate or a salt thereof, (B) an anionic surfactant, (C) a monosaccharide alcohol having 4 or more carbon atoms, an oligosaccharide alcohol, and reduced starch syrup. Or containing two or more sugar alcohols and having a calcium and aluminum ion source content of less than 10% by mass of the total composition;
A composition containing ascorbic acid phosphates, which has a pH of 8.0 or more after storage at 5 ° C. for one month.
重量比として0.5以上の割合で含有する請求項1記載
の組成物。2. The composition according to claim 1, wherein the sugar alcohol is contained in a weight ratio of 0.5 or more with respect to the water content in the composition.
物。3. The composition according to claim 1, which is for oral use.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000199213A JP4257479B2 (en) | 2000-06-30 | 2000-06-30 | Method for producing dentifrice composition containing ascorbic acid phosphate or salt thereof |
AU2001242807A AU2001242807A1 (en) | 2000-06-30 | 2001-03-27 | Compositions containing ascorbic acid phosphoric acid esters |
PCT/JP2001/002466 WO2002002124A1 (en) | 2000-06-30 | 2001-03-27 | Compositions containing ascorbic acid phosphoric acid esters |
CNB018132413A CN1245985C (en) | 2000-06-30 | 2001-03-27 | Compositions containing ascorbic acid phosphoric acid esters |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2000199213A JP4257479B2 (en) | 2000-06-30 | 2000-06-30 | Method for producing dentifrice composition containing ascorbic acid phosphate or salt thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2002020292A true JP2002020292A (en) | 2002-01-23 |
JP4257479B2 JP4257479B2 (en) | 2009-04-22 |
Family
ID=18697266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2000199213A Expired - Fee Related JP4257479B2 (en) | 2000-06-30 | 2000-06-30 | Method for producing dentifrice composition containing ascorbic acid phosphate or salt thereof |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP4257479B2 (en) |
CN (1) | CN1245985C (en) |
AU (1) | AU2001242807A1 (en) |
WO (1) | WO2002002124A1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004035416A (en) * | 2002-06-28 | 2004-02-05 | Sangi Co Ltd | Improved 3DS home care agent and caries elimination system |
JPWO2005067867A1 (en) * | 2004-01-20 | 2007-12-27 | 株式会社コーセー | Cosmetics |
WO2010143589A1 (en) * | 2009-06-08 | 2010-12-16 | ライオン株式会社 | Composition for oral cavity |
WO2010150700A1 (en) * | 2009-06-25 | 2010-12-29 | ライオン株式会社 | Dentifrice composition |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002240115B2 (en) * | 2001-01-24 | 2007-01-04 | Discus Dental, Llc. | Topical oral care compositions |
CN101247834B (en) * | 2005-06-17 | 2013-10-30 | 生命健康科学公司 | Carrier comprising one or more di and/or mono-(electron transfer agent) phosphate derivatives or complexes thereof |
WO2013133096A1 (en) * | 2012-03-07 | 2013-09-12 | ライオン株式会社 | Oral composition |
CN105663015B (en) * | 2016-03-24 | 2018-06-29 | 广州健朗医用科技有限公司 | A kind of special bee glue tooth paste of pregnant and lying-in women and preparation method thereof |
CN111759788A (en) * | 2020-07-27 | 2020-10-13 | 浙江爱尚日用品有限公司 | Toothpaste for preventing and treating dental ulcer |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2973511B2 (en) * | 1990-11-06 | 1999-11-08 | ライオン株式会社 | Oral composition |
JP2000351905A (en) * | 1999-04-05 | 2000-12-19 | Showa Denko Kk | Ascorbic acid derivative-containing composition |
-
2000
- 2000-06-30 JP JP2000199213A patent/JP4257479B2/en not_active Expired - Fee Related
-
2001
- 2001-03-27 CN CNB018132413A patent/CN1245985C/en not_active Expired - Lifetime
- 2001-03-27 WO PCT/JP2001/002466 patent/WO2002002124A1/en active Application Filing
- 2001-03-27 AU AU2001242807A patent/AU2001242807A1/en not_active Abandoned
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004035416A (en) * | 2002-06-28 | 2004-02-05 | Sangi Co Ltd | Improved 3DS home care agent and caries elimination system |
JPWO2005067867A1 (en) * | 2004-01-20 | 2007-12-27 | 株式会社コーセー | Cosmetics |
JP4589236B2 (en) * | 2004-01-20 | 2010-12-01 | 株式会社コーセー | Cosmetics |
WO2010143589A1 (en) * | 2009-06-08 | 2010-12-16 | ライオン株式会社 | Composition for oral cavity |
WO2010150700A1 (en) * | 2009-06-25 | 2010-12-29 | ライオン株式会社 | Dentifrice composition |
JP2011006351A (en) * | 2009-06-25 | 2011-01-13 | Lion Corp | Dentifrice composition |
Also Published As
Publication number | Publication date |
---|---|
WO2002002124A1 (en) | 2002-01-10 |
AU2001242807A1 (en) | 2002-01-14 |
CN1245985C (en) | 2006-03-22 |
JP4257479B2 (en) | 2009-04-22 |
CN1443072A (en) | 2003-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000154127A (en) | Composition for oral cavity | |
JPH1112142A (en) | Oral composition | |
JP2004026658A (en) | Composition for oral cavity | |
JP4257479B2 (en) | Method for producing dentifrice composition containing ascorbic acid phosphate or salt thereof | |
JP4147412B2 (en) | Oral composition | |
JP2004323488A (en) | Composition used for oral cavity and product used for oral cavity | |
JP2682020B2 (en) | Oral composition | |
JP2000256153A (en) | Oral composition | |
JP4496420B2 (en) | Dentifrice composition | |
JP2000072638A (en) | Composition for oral cavity | |
JP2001172146A (en) | Composition for oral cavity | |
JPH0925221A (en) | Fur-removing agent | |
JP2003212741A (en) | Dentifrice composition | |
JPH06239723A (en) | Composition for oral cavity | |
JP2001220336A (en) | Composition for oral cavity | |
JP3821037B2 (en) | Periodontal pathogen adhesion inhibitor and composition for oral cavity having periodontal pathogen adhesion inhibitory action | |
JP2002020254A (en) | Dentifrice preparation composition | |
JP6435852B2 (en) | Oral composition and method for preventing discoloration of oral composition | |
JP2005239653A (en) | Oral composition | |
JP2000229823A (en) | Composition for oral cavity | |
JPH0377168B2 (en) | ||
JP2001302476A (en) | Dentifrice composition | |
JPH0772125B2 (en) | Oral composition | |
JPH035416A (en) | Composition for oral cavity | |
JPH01246214A (en) | Composition for oral cavity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040914 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080528 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080718 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20080910 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20081107 |
|
A911 | Transfer of reconsideration by examiner before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20081114 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20090107 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20090120 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 4257479 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120213 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120213 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130213 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130213 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20140213 Year of fee payment: 5 |
|
LAPS | Cancellation because of no payment of annual fees |